ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,120Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 1942

$527K Total Retail Price of All Prescriptions

Rank: 73 out of 1942

521 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 521 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

7% of this provider’s 521 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 9,532 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
LEVOTHYROXINE SODIUM 642 586 1 3
SIMVASTATIN 459 407 2 1
OMEPRAZOLE 444 389 3 4
LISINOPRIL 409 369 4 2
WARFARIN SODIUM 338 316 5 11
POTASSIUM CHLORIDE 328 310 6 17
FUROSEMIDE 315 306 7 5
METOPROLOL SUCCINATE 253 242 8 13
AMLODIPINE BESYLATE 243 219 9 6
SERTRALINE HCL 236 221 10 20
TRAMADOL HCL 222 159 11 19
METOPROLOL TARTRATE 194 171 12 9
HYDROCODONE-ACETAMINOPHEN 184 132 S3 13 12
CARVEDILOL 183 160 14 39
POLYETHYLENE GLYCOL 3350 168 153 15 28
ALLOPURINOL 158 158 16 26
HYDROCHLOROTHIAZIDE 154 154 17 8
PREDNISONE 151 147 18 27
METFORMIN HCL 132 83 19 10
DIOVAN 123 111 20 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 119 117 21 22
ZOLPIDEM TARTRATE 117 67 22 25
DONEPEZIL HCL 113 102 23 30
ATENOLOL 106 106 24 7
FENTANYL 105 66 S2 25 47
NAMENDA 103 103 26 51
TRIAMTERENE-HCTZ 102 89 27 36
CITALOPRAM HBR 92 70 28 15
TAMSULOSIN HCL 85 75 29 29
DIGOXIN 82 61 30 40
AMLODIPINE BESYLATE-BENAZEPRIL 82 71 30 106
CRESTOR 81 70 32 34
LANTUS SOLOSTAR 79 51 33 54
ISOSORBIDE MONONITRATE ER 76 76 34 42
CARBIDOPA-LEVODOPA 76 73 34 64
LOSARTAN POTASSIUM 75 75 36 18
MIRTAZAPINE 74 70 37 38
GABAPENTIN 72 63 38 16
ATORVASTATIN CALCIUM 69 62 39 14
ADVAIR DISKUS 68 53 40 35
FLUOXETINE HCL 65 62 41 45
PAROXETINE HCL 62 56 42 50
ALENDRONATE SODIUM 62 50 42 21
BUSPIRONE HCL 57 57 44 133
SULFAMETHOXAZOLE-TRIMETHOPRIM 57 53 44 104
ENDOCET 56 0 S2 46 188
CELEBREX 51 48 47 93
CYMBALTA 51 46 47 62
LOSARTAN-HYDROCHLOROTHIAZIDE 50 48 49 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.